FdaApplication
NDA 204311
Identifiers
- fda_app_no: NDA204311
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | NDA |
| approval_date | 2023-12-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | EQ 60MG BASE;30MG | TABLET, FOR SUSPENSION;ORAL |
1 product